Parallax Volatility Advisers’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Parallax Volatility Advisers’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-7,020	Closed	-$88.2K	–	3631
2021 Q2	$119K	Buy	+7,020	New	+$133K	﹤0.01%	2536
2019 Q3	–	Sell	-10	Closed	-$1K	–	3775
2019 Q2	$1K	Hold	10	–	–	﹤0.01%	2458
2019 Q1	$1K	Hold	10	–	–	﹤0.01%	2676
2018 Q4	$1K	Hold	10	–	–	﹤0.01%	2822
2018 Q3	$1K	Hold	10	–	–	﹤0.01%	2505
2018 Q2	$0	Hold	10	–	–	﹤0.01%	3621
2018 Q1	$1K	Buy	+10	New	+$1.28K	﹤0.01%	2113
2017 Q4	–	Sell	-2	Closed	–	–	5178
2017 Q3	$0	Hold	2	–	–	﹤0.01%	3592
2017 Q2	$0	Hold	2	–	–	﹤0.01%	4419
2017 Q1	$0	Hold	2	–	–	﹤0.01%	4924
2016 Q4	$0	Hold	2	–	–	﹤0.01%	4452
2016 Q3	$0	Hold	2	–	–	﹤0.01%	4203
2016 Q2	$0	Hold	2	–	–	﹤0.01%	3809
2016 Q1	$0	Hold	2	–	–	﹤0.01%	3998
2015 Q4	$0	Hold	2	–	–	﹤0.01%	4172
2015 Q3	$1K	Sell	2 -4	-67%	-$4.29K	﹤0.01%	2745
2015 Q2	$5K	Buy	+6	New	+$3.85K	﹤0.01%	3319

Other funds holding EVFM

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MCP

Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Parallax Volatility Advisers's EVFM Position: Q3 2021 in Review

Parallax Volatility Advisers sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q3 2021, closing a stake of 7,020 shares — an estimated $88.2K sold.

Parallax Volatility Advisers first reported a position in EVFM in Q2 2015 and held it in 17 quarters. The position peaked at $119K in Q2 2021. 71 funds tracked by Wall St. Rank hold EVFM as of Q3 2021.

Parallax Volatility Advisers reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Parallax Volatility Advisers sold 7,020 Evofem Biosciences, Inc. Common Stock shares in Q3 2021, an estimated $88.2K.
Parallax Volatility Advisers first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2015 and held it in 17 quarters.
Parallax Volatility Advisers's Evofem Biosciences, Inc. Common Stock position peaked at $119K in Q2 2021.
71 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q3 2021.

Based on Parallax Volatility Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.